What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.
NEW YORK, Oct. 30, 2023 /PRNewswire/ — The Dental Equipment Market by End-user, Product, and Geography – Forecast and Analysis 2023-2027 report has been published by Technavio. Market size is forecast to grow by USD 12.73 billion between 2022 and 2027 at a CAGR of 6.65%. The market is…
WALTHAM, Mass., Oct. 30, 2023 /PRNewswire/ — Aeglea BioTherapeutics, Inc. (“Aeglea”) (Nasdaq: AGLE), a biotechnology company advancing a pipeline of antibody therapeutics with the potential to transform the treatment of inflammatory bowel disease (“IBD”), today announced that management…
Talks to be featured at Advanced Textiles Expo and Functional Fabric Fair HOUSTON, Oct. 30, 2023 /PRNewswire/ — Acteev experts have been tapped to share their knowledge at two upcoming expos. Cristina Acevedo, Ph.D., will discuss trends in health care at the Advanced Textiles Expo in…
NEW YORK, Oct. 30, 2023 /PRNewswire/ — The medical display monitors market in US size is expected to grow by USD 283.98 million from 2023 to 2028. In addition, the momentum of the market will be progressing at a CAGR of 7.74% during the forecast period, according to Technavio Research….
NEW YORK, Oct. 30, 2023 /PRNewswire/ — The blood bank refrigerators market size in US is expected to grow by USD 133.85 million from 2023 to 2028. In addition, the momentum of the market will progress at a CAGR of 6.28% during the forecast period, according to Technavio Research. The…
Seraphina Therapeutics Founder shows essential nutrient rivals leading anti-aging drugs in clinically relevant benefits expected to extend human longevity.
SAN DIEGO, Oct. 30, 2023 /PRNewswire-PRWeb/ — A recently published study in the scientific journal Nutrients reveals that C15:0 (pentadecanoic acid), an odd-chain healthy saturated fat found in trace amounts in dairy fat, and the first essential fatty acid to be discovered in over 90 years (since omega-3), has anti-aging properties expected to extend human longevity that equal, and even surpass, leading prescription drug candidates.
While numerous studies have linked higher C15:0 levels to lower risks of type 2 diabetes, heart disease, nonalcoholic fatty liver disease, and cancer, only recently have the anti-aging mechanisms driving these C15:0 health benefits been revealed.
“In 2020, we discovered that C15:0 directly targets multiple hallmarks of aging and effectively repaired cells throughout the human body,” said Dr. Stephanie Venn-Watson, co-founder of Seraphina Therapeutics and the lead author of the recent Nutrients paper and earlier ‘Nature’s Scientific Reports‘ paper. “Paired with the mounting science on C15:0’s long-term health benefits, we hypothesized that this nutrient plays an essential role in supporting human longevity. We were delighted by the study’s results.”
In the recent study, pure C15:0 (FA15) went head-to-head against three leading longevity drug candidates: rapamycin, metformin, and acarbose. Independent, third-party tests of all four compounds were conducted and evaluated for dose-dependent effects on clinically relevant biomarkers across 12 human cell systems mimicking various chronic disease states.
Of the four compounds, the results showed that pure C15:0 delivered the most cell repairing benefits, closely followed by rapamycin. At their optimal doses, C15:0 and rapamycin shared an impressive 24 clinically relevant activities across 10 out of the 12 human cell systems evaluated. These benefits, including anti-inflammatory, anticancer, antifibrotic, and antimicrobial activities of both C15:0 and rapamycin, align well with previously published studies. C15:0 and rapamycin have also been shown to share the ability to inhibit mTOR, which has been targeted as a key means to extend human longevity.
Dr. Nicholas Schork, the study’s co-author and Principal Investigator for the National Institutes of Health’s Longevity Consortium, points out that “the numerous benefits of C15:0, that match and even surpass that of leading candidate longevity drugs, speak to the essentiality of C15:0 to our long-term health.” Dr. Schork shares, “Remarkably, while billions of dollars have been spent around the world on advancing anti-aging research, the secret to longevity may be much closer to home.”
As a particularly urgent point, population-wide C15:0 levels have been declining, caused by avoidance of whole fat cow’s milk over the past 40 years. Given its role as an essential nutrient, it is hypothesized that nutritional C15:0 deficiencies may be driving the rise in chronic diseases among younger people, including nonalcoholic fatty liver disease (NAFLD). The most recently discovered longevity-enabling activities of C15:0 suggests that nutritional C15:0 deficiencies may help explain why human lifespans have been shortening over recent years, too.
“While global health has been declining at an alarming rate, studies are increasingly supporting that we have a new and tangible hope – the ability to readily replenish our C15:0 levels, restore aspects of our long-term health, and extend longevity for all,” states Venn-Watson.
************************************************************
About Seraphina Therapeutics. Inc.
Seraphina Therapeutics, Inc. is a health and wellness company dedicated to advancing global health through the discovery of essential fatty acids and micronutrient therapeutics. Through rigorous breakthrough science, the company develops fatty acid supplements, food fortifiers, and nutritional interventions to strengthen cells, keep mitochondria working and advance cellular homeostasis to counter age-related breakdown. With its team of industry-leading scientists, Seraphina Therapeutics challenges long-held approaches to nutrition, enabling the creation of novel health products designed to support quality of life. For more information, please visit DiscoverC15.com and fatty15.com.
Media Contact
Fatty15 Press Office, Seraphina Therapeutics, 619-407-9225, [email protected], fatty15.com
SOURCE Seraphina Therapeutics
“For the first time in the modern era, the Catholic church held conversations about previously taboo topics like ordaining women, recognizing the relationships of LGBTQIA+ people, and rethinking church power structures. We join our partners in the women’s ordination and LGBTQIA+ justice movements in expressing our deep concern about the synod’s failure to take seriously the grave injustice of gender equality and its refusal to acknowledge the longings of LGBTQIA+ Catholics for a more inclusive church.
“The church’s harmful teachings on gender and LGBTQIA+ people have profound intersections with its position on reproductive health and rights. So the synod’s continued silence on abortion — which touches the lives of far more Catholics than any of these other urgent issues — shows just how powerful and pervasive abortion stigma remains in our church.
“If Pope Francis is serious about his call to encounter each other across lines of difference, then we must talk openly and honestly about abortion, acknowledge its moral complexities, and listen to the wisdom and lived experiences of the many faithful Catholics who have abortions. That’s why I went to Rome to share the stories of Catholics for Choice who have had abortion care. The church cannot be open to the workings of the Holy Spirit on some issues while silencing conversation on others. The synod may be over for now, but the church’s work is far from finished.”
To ensure that pro-choice Catholics would not be silenced at the synod, Catholics for Choice brought our message to Rome in a series of dramatic and powerful acts:
“None of us will have true justice in our church until… patriarchal notions of gender are dismantled… [W]e are all being oppressed by the same ideology. Throwing each other under the bus because we think our particular community is getting somewhere with this pope is a deeply flawed strategy. We have to fight for each other, because we either all get justice together by dismantling this ideology once and for all, or there will be no true justice for any of us.” (Full speech available here.)
Catholics for Choice will continue to monitor the activities of the U.S. Conference of Catholic Bishops at their fall gathering on November 13-16, 2023, and the Synod on Synodality will meet for a second and final session in October 2024.
Catholics for Choice shapes and advances sexual and reproductive ethics that are based on justice, reflect a commitment to a person’s well-being and respect, and affirm the capacity of all people to make moral decisions about their lives.
Media Contact
John Becker, Catholics for Choice, 202-203-0931, Press Secretary, [email protected], www.catholicsforchoice.org
SOURCE Catholics for Choice
WASHINGTON, Oct. 30, 2023 /PRNewswire/ — The American HFC Coalition applauds the U.S. Department of Commerce for initiating an anti-circumvention inquiry to determine whether imports of Chinese hydrofluorocarbons (HFCs) are circumventing the 2016 antidumping duty order on HFC blends….
¡ÚNETE AL RETO! 12 días, 10 horas, 1 libro. CIUDAD DE MÉXICO, 30 de octubre de 2023 /PRNewswire/ — El próximo lunes 6 de noviembre se realizará el lanzamiento del audiolibro “Medicina Funcional”, podrás escuchar, analizar y desmenuzar la obra junto con su coautor, el Dr. Alexander O…
The practice is dedicated to offering the finest oral healthcare solutions using advanced technologies and materials. Dr. Alex Hodosh takes great care in developing each individual’s treatment plan based on their specific needs, emphasizing lasting dental health, function, and beauty. Dr. Hodosh believes that listening and connecting with his patients affords him the ability to truly understand their needs and tailor their treatment to them individually. He takes enormous pride in providing the finest care for his patients and believes that improving their dental health has a lasting positive impact on their quality of life.
Exceptional patient care and cutting-edge treatment are part of Hodosh Cosmetic & Implant Dentistry’s history. The practice was founded by Dr. Milton Hodosh who was a pioneer in the field of dental implants. His research, which included eleven National Institute of Health grants, established the basic principles for the development and success of dental implants. He was a prolific inventor and holder of over 40 US and foreign patents. In addition, he isolated, developed, and patented the key chemical formula for the treatment of dental hypersensitivity, which is now the essential ingredient for the leading desensitizing toothpastes worldwide. His sons, Drs. Steven and Alex Hodosh followed in his footsteps and continued to expand the practice with the most modern and up-to-date technology.
Dr. Alex Hodosh has practiced dentistry for over 35 years and still feels honored and happy to be welcomed into people’s lives. Dr. Hodosh attended Boston University, receiving a bachelor’s degree in Biology, and then went on to Tufts University School of Dental Medicine where he earned a Doctor of Dental Medicine in 1987. Dr. Hodosh also completed specialty training in Dental Implantology at the Brookdale Hospital in New York. Dental Implants have been integrated into his daily practice for the past 35 years.
Dr. Hodosh remains very active in dental advancements, presenting and lecturing at professional conferences and meetings on implant placement techniques and restoration. In addition, Dr. Hodosh is an expert in utilizing 3D technology for the treatment planning and guided surgical placement of implants. He has been an early adopter of many high-tech advancements in dental technology. He is highly skilled in the use of the CEREC 3D system for the design and fabrication of crown and bridge and implant procedures and specializes in providing same-day dentistry using these modern tools.
Dr. Hodosh grew up in Providence and has been a Rhode Island resident his entire life. When not in the office, he prioritizes time with his family and particularly enjoys engaging with his children’s various interests and activities. He also values quality time with friends and enjoys fishing and skiing. Dr. Hodosh is a big believer in giving back to the community: helping the homeless as well as supporting local youth softball leagues, local libraries, and neighborhood churches.
“I have practiced dentistry for over 35 years and still feel honored and happy to be welcomed into people’s lives, and likewise I feel honored to be welcomed into the DCA family,” shared Dr. Alex Hodosh. “I am excited for the future with this DCA partnership, and I look forward to continuing to bring to life the exceptional care and forward-looking dentistry that has been the cornerstone of my practice.”
Practicing alongside Dr. Alex Hodosh is Dr. Daniel Son. Dr. Son believes that dentistry is a way to help people lead healthier, happier, more enjoyable lives. Whether he’s providing a checkup, brightening a smile, relieving pain, or restoring function, my focus is always on what is right for the individual: he wants them to have a worry-free experience and be pleased with the results.
Dr. Son appreciates how every procedure is a combination of art, science, and personal connection. The conversations with patients, prior to designing their treatment, are key to providing optimal care. He especially enjoys educating people on their oral health, explaining what’s happening in their mouth, and how together they can address the situation.
Dr. Son completed a Bachelor of Science in Chemistry in 2010, at Carnegie Mellon University and then attended Columbia University, where he was awarded a Doctor of Dental Surgery and a Master of Arts in Science and Dental Education in 2015. Dr. Son also attended Harvard University from 2015-2018 to pursue a Master of Medical Sciences in Oral Biology and Certificate in Prosthodontics.
Both doctors strive to always provide the highest quality in clinical care, which they deliver with gentle hands, to ensure the best results. They are experienced, professional, and friendly, always aiming to make every interaction and each procedure as comfortable as possible.
This affiliation continues the rapid growth and momentum of the organization and expands DCA’s footprint into the state of Rhode Island. DCA’s total footprint includes over 400 allied practices across the US.
“Hodosh Cosmetic & Implant Dentistry occupies an important place in the history of dentistry,” shared Andrew Clarke, DCA Vice President Business Development. Dr. Hodosh and Dr. Son are exceptional doctors, and I’m excited DCA can help support them in continuing the practice’s legacy. We couldn’t be more thrilled to have them partner with DCA, along with the practice’s talented, dedicated staff.”
Dental Care Alliance’s mission is to advance the practice of dentistry by partnering with and supporting dental professionals to create a lifetime of healthy smiles. DCA currently supports over 400 allied practices and over 900 dentists across 23 states. DCA’s allied practices represent all dental specialties and treat patients under more than 150 brand names.
Media Contact
Molly Benz, Dental Care Alliance, 9419553150, [email protected], dentalcarealliance.com
SOURCE Dental Care Alliance
